Fundraising FoxRaptor Group — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers.
AI & Machine LearningBiotechHealthtechBrooklyn, US
Stacy Blain(Founder, CEO)inLisaMarie Casey(President and Manager)Dustin Mraz(Executive Board Member / Co-founder)
BoardJason Mraz(Executive Board Member)in
PartnerJames J. Pallotta· solo GP
Co-investorsBioAdvanceCatalytic Impact FoundationCreative Destruction Lab (CDL)
Templum provides software for managing alternative investment offerings, with modules for investors, advisors, and administrators to place orders, track holdings, and oversee the full investment lifecycle.
B2B MarketplacesEnterprise SoftwareFintechSaaSMiami Beach, US
Christopher Pallotta(Executive Officer, Director)inSarah Gillespie(Executive Officer)inJoseph Ramos(Executive Officer)inScott Kalish(Executive Officer)inChris Pallotta
BoardPeter Monaco(Director)
PartnerJames J. Pallotta· solo GP
Co-investorsBlockchain Capitalfirstminute capitalSBI HoldingsWestCap
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.